Detalhe da pesquisa
1.
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.
N Engl J Med
; 385(22): 2059-2065, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818480
2.
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 71(7): e31051, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706187
3.
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.
Pediatr Blood Cancer
; 71(1): e30743, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885116
4.
Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.
Clin Trials
; 21(2): 211-219, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961910
5.
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020.
Pediatr Blood Cancer
; 70(5): e30106, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458672
6.
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 70(2): e30054, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316811
7.
Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors.
Pediatr Blood Cancer
; 70(11): e30652, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644664
8.
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
Pediatr Blood Cancer
; 70 Suppl 6: e30583, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501549
9.
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Pediatr Blood Cancer
; 70 Suppl 6: e30572, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458162
10.
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma.
Pediatr Blood Cancer
; 70(12): e30681, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715723
11.
NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations.
J Pediatr Hematol Oncol
; 45(4): 165-173, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219702
12.
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.
Br J Cancer
; 127(12): 2220-2226, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36221002
13.
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
Histopathology
; 81(2): 215-227, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543076
14.
68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma.
Pediatr Blood Cancer
; 69(8): e29740, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484995
15.
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 69(9): e29616, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188340
16.
Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.
Pediatr Blood Cancer
; 69(2): e29396, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662499
17.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
18.
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.
Pediatr Blood Cancer
; 68(2): e28807, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219750
19.
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Pediatr Blood Cancer
; 68(3): e28834, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258278
20.
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(12): e29333, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496122